IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects

Amal Hasan, Fahad Al-Ghimlas, Samia Warsame, Asma Al-Hubail, Rasheed Ahmad, Abdullah Bennakhi, Monira Al-Arouj, Kazem Behbehani, Mohammed Dehbi, Said Dermime

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: Recent studies have demonstrated a protective role for IL-33 against obesity-associated inflammation, atherosclerosis and metabolic abnormalities. IL-33 promotes the production of T helper type 2 (Th2) cytokines, polarizes macrophages towards a protective alternatively activated phenotype, reduces lipid storage and decreases the expression of genes associated with lipid metabolism and adipogenesis. Our objective was to determine the level of serum IL-33 in non-diabetic and diabetic subjects, and to correlate these levels with clinical (BMI and body weight) and metabolic (serum lipids and HbA1c) parameters. Methods: The level of IL-33 was measured in the serum of lean, overweight and obese non-diabetic and diabetic subjects, and then correlated with clinical and metabolic parameters. Results: Non-lean subjects had significantly (P = 0.01) lower levels of IL-33 compared to lean controls. IL-33 was negatively correlated with the BMI and body weight in lean and overweight, but not obese (non-diabetic and diabetic), subjects. IL-33 is associated with protective lipid profiles, and is negatively correlated with HbA1c, in non-diabetic (lean, overweight and obese) but not diabetic subjects. Conclusions: Our data support previous findings showing a protective role for IL-33 against adiposity and atherosclerosis, and further suggest that reduced levels of IL-33 may put certain individuals at increased risk of developing atherosclerosis and insulin resistance. Therefore, IL-33 may serve as a novel marker to predict those who may be at increased risk of developing atherosclerosis.

Original languageEnglish
Article number19
JournalBMC Immunology
Volume15
Issue number1
DOIs
Publication statusPublished - 10 May 2014

    Fingerprint

Keywords

  • Atherosclerosis
  • BMI
  • HDL-C
  • Interleukin-33
  • LDL-C
  • TGL

Cite this

Hasan, A., Al-Ghimlas, F., Warsame, S., Al-Hubail, A., Ahmad, R., Bennakhi, A., Al-Arouj, M., Behbehani, K., Dehbi, M., & Dermime, S. (2014). IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. BMC Immunology, 15(1), [19]. https://doi.org/10.1186/1471-2172-15-19